COVID-19 Outbreak-Global Injectable or Inhaled Pain Drug Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
The Injectable or Inhaled Pain Drug market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Injectable or Inhaled Pain Drug industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Injectable or Inhaled Pain Drug market can be split based on product types, major applications, and important countries as follows:
Key players in the global Injectable or Inhaled Pain Drug market covered in Chapter 12:
Eli Lilly and Company
Nektar Therapeutics
Johnson & Johnson
F. Hoffmann La Roche Ltd.,
Pfizer, Inc.
GlaxoSmithKline Plc
Teva Pharmaceutical Industries Ltd.
AcelRx Pharmaceuticals, Inc.
Abbott Laboratories
Purdue Pharma L.P.
KemPharm, Inc.
Mylan N.V.
Sanofi S.A.
In Chapter 4 and 14.1, on the basis of types, the Injectable or Inhaled Pain Drug market from 2015 to 2025 is primarily split into:
Injectable Pain Drug
Inhaled Pain Drug
In Chapter 5 and 14.2, on the basis of applications, the Injectable or Inhaled Pain Drug market from 2015 to 2025 covers:
Pharmacy
Hospital
Clinic
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Injectable or Inhaled Pain Drug Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Injectable or Inhaled Pain Drug
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Injectable or Inhaled Pain Drug industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Injectable or Inhaled Pain Drug Market Size, 2015 – 2020
2.1.2 Global Injectable or Inhaled Pain Drug Market Size by Type, 2015 – 2020
2.1.3 Global Injectable or Inhaled Pain Drug Market Size by Application, 2015 – 2020
2.1.4 Global Injectable or Inhaled Pain Drug Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Injectable or Inhaled Pain Drug Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Injectable or Inhaled Pain Drug Analysis
3.2 Major Players of Injectable or Inhaled Pain Drug
3.3 Injectable or Inhaled Pain Drug Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Injectable or Inhaled Pain Drug
3.3.3 Labor Cost of Injectable or Inhaled Pain Drug
3.4 Market Distributors of Injectable or Inhaled Pain Drug
3.5 Major Downstream Buyers of Injectable or Inhaled Pain Drug Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Injectable or Inhaled Pain Drug Market, by Type
4.1 Global Injectable or Inhaled Pain Drug Value and Market Share by Type (2015-2020)
4.2 Global Injectable or Inhaled Pain Drug Production and Market Share by Type (2015-2020)
4.3 Global Injectable or Inhaled Pain Drug Value and Growth Rate by Type (2015-2020)
4.3.1 Global Injectable or Inhaled Pain Drug Value and Growth Rate of Injectable Pain Drug
4.3.2 Global Injectable or Inhaled Pain Drug Value and Growth Rate of Inhaled Pain Drug
4.4 Global Injectable or Inhaled Pain Drug Price Analysis by Type (2015-2020)
5 Injectable or Inhaled Pain Drug Market, by Application
5.1 Downstream Market Overview
5.2 Global Injectable or Inhaled Pain Drug Consumption and Market Share by Application (2015-2020)
5.3 Global Injectable or Inhaled Pain Drug Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Injectable or Inhaled Pain Drug Consumption and Growth Rate of Pharmacy (2015-2020)
5.3.2 Global Injectable or Inhaled Pain Drug Consumption and Growth Rate of Hospital (2015-2020)
5.3.3 Global Injectable or Inhaled Pain Drug Consumption and Growth Rate of Clinic (2015-2020)
5.3.4 Global Injectable or Inhaled Pain Drug Consumption and Growth Rate of Others (2015-2020)
6 Global Injectable or Inhaled Pain Drug Market Analysis by Regions
6.1 Global Injectable or Inhaled Pain Drug Sales, Revenue and Market Share by Regions
6.1.1 Global Injectable or Inhaled Pain Drug Sales by Regions (2015-2020)
6.1.2 Global Injectable or Inhaled Pain Drug Revenue by Regions (2015-2020)
6.2 North America Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
6.3 Europe Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
6.6 South America Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
7 North America Injectable or Inhaled Pain Drug Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Injectable or Inhaled Pain Drug Sales, Revenue and Market Share by Countries
7.2.1 North America Injectable or Inhaled Pain Drug Sales by Countries (2015-2020)
7.2.2 North America Injectable or Inhaled Pain Drug Revenue by Countries (2015-2020)
7.3 United States Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
7.4 Canada Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
7.5 Mexico Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
8 Europe Injectable or Inhaled Pain Drug Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Injectable or Inhaled Pain Drug Sales, Revenue and Market Share by Countries
8.2.1 Europe Injectable or Inhaled Pain Drug Sales by Countries (2015-2020)
8.2.2 Europe Injectable or Inhaled Pain Drug Revenue by Countries (2015-2020)
8.3 Germany Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
8.4 UK Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
8.5 France Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
8.6 Italy Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
8.7 Spain Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
8.8 Russia Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
9 Asia Pacific Injectable or Inhaled Pain Drug Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Injectable or Inhaled Pain Drug Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Injectable or Inhaled Pain Drug Sales by Countries (2015-2020)
9.2.2 Asia Pacific Injectable or Inhaled Pain Drug Revenue by Countries (2015-2020)
9.3 China Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
9.4 Japan Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
9.5 South Korea Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
9.6 India Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
9.8 Australia Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
10 Middle East and Africa Injectable or Inhaled Pain Drug Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Injectable or Inhaled Pain Drug Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Injectable or Inhaled Pain Drug Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Injectable or Inhaled Pain Drug Revenue by Countries (2015-2020)
10.3 Saudi Arabia Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
10.4 UAE Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
10.5 Egypt Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
10.6 Nigeria Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
10.7 South Africa Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
11 South America Injectable or Inhaled Pain Drug Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Injectable or Inhaled Pain Drug Sales, Revenue and Market Share by Countries
11.2.1 South America Injectable or Inhaled Pain Drug Sales by Countries (2015-2020)
11.2.2 South America Injectable or Inhaled Pain Drug Revenue by Countries (2015-2020)
11.3 Brazil Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
11.4 Argentina Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
11.5 Columbia Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
11.6 Chile Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Eli Lilly and Company
12.1.1 Eli Lilly and Company Basic Information
12.1.2 Injectable or Inhaled Pain Drug Product Introduction
12.1.3 Eli Lilly and Company Production, Value, Price, Gross Margin 2015-2020
12.2 Nektar Therapeutics
12.2.1 Nektar Therapeutics Basic Information
12.2.2 Injectable or Inhaled Pain Drug Product Introduction
12.2.3 Nektar Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Basic Information
12.3.2 Injectable or Inhaled Pain Drug Product Introduction
12.3.3 Johnson & Johnson Production, Value, Price, Gross Margin 2015-2020
12.4 F. Hoffmann La Roche Ltd.,
12.4.1 F. Hoffmann La Roche Ltd., Basic Information
12.4.2 Injectable or Inhaled Pain Drug Product Introduction
12.4.3 F. Hoffmann La Roche Ltd., Production, Value, Price, Gross Margin 2015-2020
12.5 Pfizer, Inc.
12.5.1 Pfizer, Inc. Basic Information
12.5.2 Injectable or Inhaled Pain Drug Product Introduction
12.5.3 Pfizer, Inc. Production, Value, Price, Gross Margin 2015-2020
12.6 GlaxoSmithKline Plc
12.6.1 GlaxoSmithKline Plc Basic Information
12.6.2 Injectable or Inhaled Pain Drug Product Introduction
12.6.3 GlaxoSmithKline Plc Production, Value, Price, Gross Margin 2015-2020
12.7 Teva Pharmaceutical Industries Ltd.
12.7.1 Teva Pharmaceutical Industries Ltd. Basic Information
12.7.2 Injectable or Inhaled Pain Drug Product Introduction
12.7.3 Teva Pharmaceutical Industries Ltd. Production, Value, Price, Gross Margin 2015-2020
12.8 AcelRx Pharmaceuticals, Inc.
12.8.1 AcelRx Pharmaceuticals, Inc. Basic Information
12.8.2 Injectable or Inhaled Pain Drug Product Introduction
12.8.3 AcelRx Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2015-2020
12.9 Abbott Laboratories
12.9.1 Abbott Laboratories Basic Information
12.9.2 Injectable or Inhaled Pain Drug Product Introduction
12.9.3 Abbott Laboratories Production, Value, Price, Gross Margin 2015-2020
12.10 Purdue Pharma L.P.
12.10.1 Purdue Pharma L.P. Basic Information
12.10.2 Injectable or Inhaled Pain Drug Product Introduction
12.10.3 Purdue Pharma L.P. Production, Value, Price, Gross Margin 2015-2020
12.11 KemPharm, Inc.
12.11.1 KemPharm, Inc. Basic Information
12.11.2 Injectable or Inhaled Pain Drug Product Introduction
12.11.3 KemPharm, Inc. Production, Value, Price, Gross Margin 2015-2020
12.12 Mylan N.V.
12.12.1 Mylan N.V. Basic Information
12.12.2 Injectable or Inhaled Pain Drug Product Introduction
12.12.3 Mylan N.V. Production, Value, Price, Gross Margin 2015-2020
12.13 Sanofi S.A.
12.13.1 Sanofi S.A. Basic Information
12.13.2 Injectable or Inhaled Pain Drug Product Introduction
12.13.3 Sanofi S.A. Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Injectable or Inhaled Pain Drug Market Forecast
14.1 Global Injectable or Inhaled Pain Drug Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Injectable Pain Drug Market Value and Volume Forecast (2020-2025)
14.1.2 Inhaled Pain Drug Market Value and Volume Forecast (2020-2025)
14.2 Global Injectable or Inhaled Pain Drug Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Pharmacy Market Value and Volume Forecast (2020-2025)
14.2.2 Hospital Market Value and Volume Forecast (2020-2025)
14.2.3 Clinic Market Value and Volume Forecast (2020-2025)
14.2.4 Others Market Value and Volume Forecast (2020-2025)
14.3 Injectable or Inhaled Pain Drug Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Injectable or Inhaled Pain Drug
Table Product Specification of Injectable or Inhaled Pain Drug
Table Injectable or Inhaled Pain Drug Key Market Segments
Table Key Players Injectable or Inhaled Pain Drug Covered
Figure Global Injectable or Inhaled Pain Drug Market Size, 2015 – 2025
Table Different Types of Injectable or Inhaled Pain Drug
Figure Global Injectable or Inhaled Pain Drug Value ($) Segment by Type from 2015-2020
Figure Global Injectable or Inhaled Pain Drug Market Share by Types in 2019
Table Different Applications of Injectable or Inhaled Pain Drug
Figure Global Injectable or Inhaled Pain Drug Value ($) Segment by Applications from 2015-2020
Figure Global Injectable or Inhaled Pain Drug Market Share by Applications in 2019
Figure Global Injectable or Inhaled Pain Drug Market Share by Regions in 2019
Figure North America Injectable or Inhaled Pain Drug Production Value ($) and Growth Rate (2015-2020)
Figure Europe Injectable or Inhaled Pain Drug Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Injectable or Inhaled Pain Drug Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Injectable or Inhaled Pain Drug Production Value ($) and Growth Rate (2015-2020)
Figure South America Injectable or Inhaled Pain Drug Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Injectable or Inhaled Pain Drug
Table Upstream Raw Material Suppliers of Injectable or Inhaled Pain Drug with Contact Information
Table Major Players Headquarters, and Service Area of Injectable or Inhaled Pain Drug
Figure Major Players Production Value Market Share of Injectable or Inhaled Pain Drug in 2019
Table Major Players Injectable or Inhaled Pain Drug Product Types in 2019
Figure Production Process of Injectable or Inhaled Pain Drug
Figure Manufacturing Cost Structure of Injectable or Inhaled Pain Drug
Figure Channel Status of Injectable or Inhaled Pain Drug
Table Major Distributors of Injectable or Inhaled Pain Drug with Contact Information
Table Major Downstream Buyers of Injectable or Inhaled Pain Drug with Contact Information
Table Global Injectable or Inhaled Pain Drug Value ($) by Type (2015-2020)
Table Global Injectable or Inhaled Pain Drug Value Share by Type (2015-2020)
Figure Global Injectable or Inhaled Pain Drug Value Share by Type (2015-2020)
Table Global Injectable or Inhaled Pain Drug Production by Type (2015-2020)
Table Global Injectable or Inhaled Pain Drug Production Share by Type (2015-2020)
Figure Global Injectable or Inhaled Pain Drug Production Share by Type (2015-2020)
Figure Global Injectable or Inhaled Pain Drug Value ($) and Growth Rate of Injectable Pain Drug (2015-2020)
Figure Global Injectable or Inhaled Pain Drug Value ($) and Growth Rate of Inhaled Pain Drug (2015-2020)
Figure Global Injectable or Inhaled Pain Drug Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Injectable or Inhaled Pain Drug Consumption by Application (2015-2020)
Table Global Injectable or Inhaled Pain Drug Consumption Market Share by Application (2015-2020)
Figure Global Injectable or Inhaled Pain Drug Consumption Market Share by Application (2015-2020)
Figure Global Injectable or Inhaled Pain Drug Consumption and Growth Rate of Pharmacy (2015-2020)
Figure Global Injectable or Inhaled Pain Drug Consumption and Growth Rate of Hospital (2015-2020)
Figure Global Injectable or Inhaled Pain Drug Consumption and Growth Rate of Clinic (2015-2020)
Figure Global Injectable or Inhaled Pain Drug Consumption and Growth Rate of Others (2015-2020)
Figure Global Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure Global Injectable or Inhaled Pain Drug Revenue (M USD) and Growth (2015-2020)
Table Global Injectable or Inhaled Pain Drug Sales by Regions (2015-2020)
Table Global Injectable or Inhaled Pain Drug Sales Market Share by Regions (2015-2020)
Table Global Injectable or Inhaled Pain Drug Revenue (M USD) by Regions (2015-2020)
Table Global Injectable or Inhaled Pain Drug Revenue Market Share by Regions (2015-2020)
Table Global Injectable or Inhaled Pain Drug Revenue Market Share by Regions in 2015
Table Global Injectable or Inhaled Pain Drug Revenue Market Share by Regions in 2019
Figure North America Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure Europe Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure South America Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Injectable or Inhaled Pain Drug Revenue (M USD) and Growth (2015-2020)
Table North America Injectable or Inhaled Pain Drug Sales by Countries (2015-2020)
Table North America Injectable or Inhaled Pain Drug Sales Market Share by Countries (2015-2020)
Table North America Injectable or Inhaled Pain Drug Revenue (M USD) by Countries (2015-2020)
Table North America Injectable or Inhaled Pain Drug Revenue Market Share by Countries (2015-2020)
Figure United States Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure Canada Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure Mexico Injectable or Inhaled Pain Drug Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Injectable or Inhaled Pain Drug Revenue (M USD) and Growth (2015-2020)
Table Europe Injectable or Inhaled Pain Drug Sales by Countries (2015-2020)
Table Europe Injectable or Inhaled Pain Drug Sales Market Share by Countries (2015-2020)
Table Europe Injectable or Inhaled Pain Drug Revenue (M USD) by Countries (2015-2020)
Table Europe Injectable or Inhaled Pain Drug Revenue Market Share by Countries (2015-2020)
Figure Germany Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure UK Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure France Injectable or Inhaled Pain Drug Sales and Growth (2015-2020)
Figure Italy Injectable or Inhaled Pain Drug Sales and Growth (2015-2020)
Figure Spain Injectable or Inhaled Pain Drug Sales and Growth (2015-2020)
Figure Russia Injectable or Inhaled Pain Drug Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Injectable or Inhaled Pain Drug Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Injectable or Inhaled Pain Drug Sales by Countries (2015-2020)
Table Asia Pacific Injectable or Inhaled Pain Drug Sales Market Share by Countries (2015-2020)
Table Asia Pacific Injectable or Inhaled Pain Drug Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Injectable or Inhaled Pain Drug Revenue Market Share by Countries (2015-2020)
Figure China Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure Japan Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure South Korea Injectable or Inhaled Pain Drug Sales and Growth (2015-2020)
Figure India Injectable or Inhaled Pain Drug Sales and Growth (2015-2020)
Figure Southeast Asia Injectable or Inhaled Pain Drug Sales and Growth (2015-2020)
Figure Australia Injectable or Inhaled Pain Drug Sales and Growth (2015-2020)
Figure Middle East Injectable or Inhaled Pain Drug Revenue (M USD) and Growth (2015-2020)
Table Middle East Injectable or Inhaled Pain Drug Sales by Countries (2015-2020)
Table Middle East and Africa Injectable or Inhaled Pain Drug Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Injectable or Inhaled Pain Drug Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Injectable or Inhaled Pain Drug Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure UAE Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure Egypt Injectable or Inhaled Pain Drug Sales and Growth (2015-2020)
Figure Nigeria Injectable or Inhaled Pain Drug Sales and Growth (2015-2020)
Figure South Africa Injectable or Inhaled Pain Drug Sales and Growth (2015-2020)
Figure South America Injectable or Inhaled Pain Drug Revenue (M USD) and Growth (2015-2020)
Table South America Injectable or Inhaled Pain Drug Sales by Countries (2015-2020)
Table South America Injectable or Inhaled Pain Drug Sales Market Share by Countries (2015-2020)
Table South America Injectable or Inhaled Pain Drug Revenue (M USD) by Countries (2015-2020)
Table South America Injectable or Inhaled Pain Drug Revenue Market Share by Countries (2015-2020)
Figure Brazil Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure Argentina Injectable or Inhaled Pain Drug Sales and Growth Rate (2015-2020)
Figure Columbia Injectable or Inhaled Pain Drug Sales and Growth (2015-2020)
Figure Chile Injectable or Inhaled Pain Drug Sales and Growth (2015-2020)
Figure Top 3 Market Share of Injectable or Inhaled Pain Drug Companies in 2019
Figure Top 6 Market Share of Injectable or Inhaled Pain Drug Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Eli Lilly and Company Profile
Table Eli Lilly and Company Product Introduction
Figure Eli Lilly and Company Production and Growth Rate
Figure Eli Lilly and Company Value ($) Market Share 2015-2020
Table Nektar Therapeutics Profile
Table Nektar Therapeutics Product Introduction
Figure Nektar Therapeutics Production and Growth Rate
Figure Nektar Therapeutics Value ($) Market Share 2015-2020
Table Johnson & Johnson Profile
Table Johnson & Johnson Product Introduction
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Value ($) Market Share 2015-2020
Table F. Hoffmann La Roche Ltd., Profile
Table F. Hoffmann La Roche Ltd., Product Introduction
Figure F. Hoffmann La Roche Ltd., Production and Growth Rate
Figure F. Hoffmann La Roche Ltd., Value ($) Market Share 2015-2020
Table Pfizer, Inc. Profile
Table Pfizer, Inc. Product Introduction
Figure Pfizer, Inc. Production and Growth Rate
Figure Pfizer, Inc. Value ($) Market Share 2015-2020
Table GlaxoSmithKline Plc Profile
Table GlaxoSmithKline Plc Product Introduction
Figure GlaxoSmithKline Plc Production and Growth Rate
Figure GlaxoSmithKline Plc Value ($) Market Share 2015-2020
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Product Introduction
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Value ($) Market Share 2015-2020
Table AcelRx Pharmaceuticals, Inc. Profile
Table AcelRx Pharmaceuticals, Inc. Product Introduction
Figure AcelRx Pharmaceuticals, Inc. Production and Growth Rate
Figure AcelRx Pharmaceuticals, Inc. Value ($) Market Share 2015-2020
Table Abbott Laboratories Profile
Table Abbott Laboratories Product Introduction
Figure Abbott Laboratories Production and Growth Rate
Figure Abbott Laboratories Value ($) Market Share 2015-2020
Table Purdue Pharma L.P. Profile
Table Purdue Pharma L.P. Product Introduction
Figure Purdue Pharma L.P. Production and Growth Rate
Figure Purdue Pharma L.P. Value ($) Market Share 2015-2020
Table KemPharm, Inc. Profile
Table KemPharm, Inc. Product Introduction
Figure KemPharm, Inc. Production and Growth Rate
Figure KemPharm, Inc. Value ($) Market Share 2015-2020
Table Mylan N.V. Profile
Table Mylan N.V. Product Introduction
Figure Mylan N.V. Production and Growth Rate
Figure Mylan N.V. Value ($) Market Share 2015-2020
Table Sanofi S.A. Profile
Table Sanofi S.A. Product Introduction
Figure Sanofi S.A. Production and Growth Rate
Figure Sanofi S.A. Value ($) Market Share 2015-2020
Table Market Driving Factors of Injectable or Inhaled Pain Drug
Table Merger, Acquisition and New Investment
Table Global Injectable or Inhaled Pain Drug Market Value ($) Forecast, by Type
Table Global Injectable or Inhaled Pain Drug Market Volume Forecast, by Type
Figure Global Injectable or Inhaled Pain Drug Market Value ($) and Growth Rate Forecast of Injectable Pain Drug (2020-2025)
Figure Global Injectable or Inhaled Pain Drug Market Volume ($) and Growth Rate Forecast of Injectable Pain Drug (2020-2025)
Figure Global Injectable or Inhaled Pain Drug Market Value ($) and Growth Rate Forecast of Inhaled Pain Drug (2020-2025)
Figure Global Injectable or Inhaled Pain Drug Market Volume ($) and Growth Rate Forecast of Inhaled Pain Drug (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Pharmacy (2020-2025)
Figure Market Volume and Growth Rate Forecast of Pharmacy (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Hospital (2020-2025)
Figure Market Volume and Growth Rate Forecast of Hospital (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Clinic (2020-2025)
Figure Market Volume and Growth Rate Forecast of Clinic (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Market Volume and Growth Rate Forecast of Others (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|